Small Molecules

23 Aug 2017 Cancer Research UK launches trial to test new drug in patients with advanced cancer
23 Aug 2017 Ultragenyx Announces Top-Line Results from Phase 3 Study of Ace-ER in GNE Myopathy
23 Aug 2017 Curtana Pharmaceuticals Successfully Completes Pre-IND Submission for CT-179 for the Treatment of Malignant Gliomas
22 Aug 2017 PharmAkea Announces Successful Completion of a Phase 1 Trial in Healthy Subjects For Its Novel LOXL2 Inhibitor, PAT-1251
22 Aug 2017 Teikoku Pharma USA Announces Positive Topline Results from Phase 2 Clinical Trial of TPU-006, Non‑Opioid Pain Management Patch in Bunionectomy Surgery
22 Aug 2017 Lakewood-Amedex Inc. Completes Clinical Trial Recruitment for Final Cohort of the Company's Phase 1/2a Program in Patients with Infected Diabetic Foot Ulcers
22 Aug 2017 First Patient Dosed in Phase 3 MORPHO Trial Evaluating Gilteritinib as Maintenance Therapy Following Hematopoietic Stem Cell Transplant in Patients with FLT3 Mutation-positive Acute Myeloid Leukemia
22 Aug 2017 Cardiome provides U.S. regulatory update for brinavess
21 Aug 2017 Alkermes Initiates Rolling Submission of ALKS 5461 New Drug Application for Major Depressive Disorder
21 Aug 2017 Ironwood Pharmaceuticals Announces FDA Approval of DUZALLO® (lesinurad and allopurinol) for the Treatment of Hyperuricemia in Patients with Uncontrolled Gout
21 Aug 2017 Ovid Therapeutics Announces First Patient Randomized in Phase 1b/2a Clinical Trial of TAK-935/OV935 in Adults with Rare Epilepsies
21 Aug 2017 New XARELTO® (rivaroxaban) Data at ESC Congress 2017 Includes Late-Breaking Results from Landmark Phase 3 COMPASS Study
21 Aug 2017 Saniona AB: Saniona's partner, Medix, initiates Phase 3 study for tesofensine in obesity
21 Aug 2017 Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156, a novel compound against multidrug-resistant malaria
20 Aug 2017 Mithra announces first subject completes ESTELLE® phase III study
18 Aug 2017 Medivir initiates clinical study of birinapant in combination with KEYTRUDA® (pembrolizumab) in patients with treatment-refractory solid tumours
18 Aug 2017 Lynparza receives additional and broad approval in the US for ovarian cancer
17 Aug 2017 Trovagene's PLK1 Inhibitor PCM-075, in Preclinical AML Data, Significantly Enhances the Efficacy of a FLT3 inhibitor in Combination Therapy
17 Aug 2017 PolyPid Ltd. Completes Enrollment in Phase Ib/II Study of D-PLEX™ in Post-Cardiac Surgery Sternal Infection
17 Aug 2017 Tetraphase Pharmaceuticals Announces Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency
17 Aug 2017 Exelixis Submits U.S. Supplemental New Drug Application for CABOMETYX® (cabozantinib) for the Treatment of Previously Untreated Advanced Kidney Cancer
16 Aug 2017 FDA Accepts Medivir´s IND Application for MIV-711, Enabling Clinical Development in the US
15 Aug 2017 ONC201 Trial for Neuroendocrine Cancer Begins at Cleveland Clinic
15 Aug 2017 Saniona AB: Saniona's partner, Luc Therapeutics, nominates clinical candidate and initiates preclinical development in joint Ataxia program
15 Aug 2017 Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing